Oxford BioMedica(OXBDF)
$7.13-0.21 (-2.80%)
OXBDF
Oxford BioMedica earnings date
$7.13
At close:-0.21 (-2.80%)
Oxford BioMedica (OXBDF) Q4 2021 Earnings Report
64 Followers
OXBDF Q4 2021 EPS Results
- Actual EPS
- $0.01
- Consensus EPS
- $0.08
- Beat/Miss
- Missed by -$0.07
- One Year Ago EPS
- $0.01
OXBDF Q4 2021 Revenue Results
- Actual Revenue
- $81.51M
- Expected Revenue
- $75.42M
- Beat/Miss
- Beat by +$6.08M
- YoY Revenue Growth
- +14.50%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 04/20/2022
- Time
- Before Open
- Conference Call
- Wednesday, April 20, 2022
OXBDF Upcoming Earnings
Oxford BioMedica's next earnings date is estimated for April 15, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
OXBDF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 15, 2027 | 2026 (Q4) | -0.03- | -0.07 | ― | ― |
| Sep 22, 2026 | 2026 (Q2) | -0.38-0.40 | -0.34 | -19.69% (-0.07) | |
| Mar 26, 2026 | 2025 (Q4) | -0.10-0.07 | -0.1 | 29.87% (+0.03) | |
| Sep 23, 2025 | 2025 (Q2) | -0.32-0.34 | -0.41 | 17.80% (+0.07) | |
| Apr 09, 2025 | 2024 (Q4) | -0.10-0.10 | -1.5 | 93.21% (+1.40) | |
| Sep 23, 2024 | 2024 (Q2) | -0.37-0.41 | -0.66 | 37.83% (+0.25) | |
| Apr 29, 2024 | 2023 (Q4) | -0.65-1.50 | -0.19 | -682.07% (-1.31) | |
| Sep 20, 2023 | 2023 (Q2) | -0.47-0.66 | -0.36 | -82.05% (-0.30) | |
| Apr 25, 2023 | 2022 (Q4) | -0.09-0.19 | 0.01 | -1418.18% (-0.21) | |
| Sep 15, 2022 | 2022 (Q2) | -0.10-0.36 | 0.28 | -227.57% (-0.64) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
